Profibrogenic phenotype in caveolin-1 deficiency via differential regulation of STAT-1/3 proteins

Biochemistry and Cell Biology

Volumn 92, Issue 5, 2014, Pages 370-378

  Ryter, Stefan W ^a,b   Choi, Augustine M K ^a,b   Kim, Hong Pyo ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Ajou University   (South Korea)

Author keywords

Antifibrogenic; Caveolin 1; Lipid raft; Protein tyrosine phosphatae 1B; Signal transducers and activators of transcription

Indexed keywords

AMINO ACIDS; BIOLOGICAL ORGANS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CHEMICAL ACTIVATION; FIBROBLASTS; GENE EXPRESSION; TRANSCRIPTION; TRANSDUCERS;

ANTIFIBROGENIC; CAVEOLIN-1; DIFFERENTIAL REGULATION; LIPID RAFT; PLATELET-DERIVED GROWTH FACTORS; PROTEIN-TYROSINE PHOSPHATASE; SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTIONS; TRANSFORMING GROWTH FACTORS;

PROTEINS;

ALPHA SMOOTH MUSCLE ACTIN; CAVEOLIN 1; JANUS KINASE 2; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN TYROSINE PHOSPHATASE 1B; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; JAK2 PROTEIN, MOUSE; PROTEIN KINASE TYK2; STAT1 PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE; TYK2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FIBROGENESIS; GENE DELETION; GENE FUNCTION; KIDNEY; LIPID RAFT; LIVER; LUNG FIBROBLAST; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENETICS; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CAVEOLIN 1; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; FIBROSIS; JANUS KINASE 2; LUNG; MEMBRANE MICRODOMAINS; MICE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TYK2 KINASE;

EID: 84911024716     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0075     Document Type: Article

References (33)

1. Borza C.M. Chen X. Mathew S. Mont S. Sanders C.R. Zent R. Pozzi A. 2010. Integrin {alpha}1{beta}1 promotes caveolin-1 dephosphorylation by activating T cell protein-tyrosine phosphatase. J. Biol. Chem. 285: 40114-40124. 10.1074/jbc.M110.156729. 20940300.
2. Bourdeau A. Dube N. Tremblay M.L. 2005. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr. Opin. Cell Biol. 17: 203-209. 10.1016/j.ceb.2005.02.001. 15780598.
3. Coskun M. Salem M. Pedersen J. Nielsen O.H. 2013. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol. Res. 76: 1-8. 10.1016/j.phrs.2013.06.007. 23827161.
4. Dadke S. Cotteret S. Yip S.C. Jaffer Z.M. Haj F. Ivanov A. et al 2007. Regulation of protein tyrosine phosphatase 1B by sumoylation. Nat. Cell Biol. 9: 80-85. 10.1038/ncb1522. 17159996.
5. Feldhammer M. Uetani N. Miranda-Saavedra D. Tremblay M.L. 2013. PTP1B: a simple enzyme for a complex world. Crit. Rev. Biochem. Mol. Biol. 248: 430-445. 10.3109/10409238.2013.819830. 23879520.
6. Fernández M.A. Albor C. Ingelmo-Torres M. Nixon S.J. Ferguson C. Kurzchalia T. et al 2006. Caveolin-1 is essential for liver regeneration. Science, 313: 1628-1632. 10.1126/science.1130773. 16973879.
7. Guo X. Qiu J. Tu T. Yang X. Deng L. Anders R.A. et al 2014. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity, 40 (1): 25-39. 10.1016/j.immuni.2013.10.021. 24412612.
8. Gvaramia D. Blaauboer M.E. Hanemaaijer R. Everts V. 2013. Role of caveolin-1 in fibrotic diseases. Matrix Biol. 32 (6): 307-315. 10.1016/j.matbio.2013.03.005. 23583521.
9. Haj F.G. Verveer P.J. Squire A. Neel B.G. Bastiaens P.I. 2002. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science, 95: 1708-1711. 10.1126/science.1067566. 11872838.
10. Haura E.B. Turkson J. Jove R. 2005. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat. Clin. Pract. Oncol. 2: 315-324. 10.1038/ncponc0195. 16264989.
11. Her N.G. Jeong S.I. Cho K. Ha T.K. Han J. Ko K.P. et al 2013. PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway. Cell Cycle, 12 (10): 1521-1035. 10.4161/cc.24636. 23598720.
12. Hernández M.V. Sala M.G. Balsamo J. Lilien J. Arregui C.O. 2006. ER-bound PTP1B is targeted to newly forming cell-matrix adhesions. J. Cell Sci. 119: 1233-1243. 10.1242/jcs.02846. 16522684.
13. Kim H.P. Wang X. Nakao A. Kim S.I. Murase N. Choi M.E. et al 2005. Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc. Natl. Acad. Sci. U.S.A. 102: 11319-11324. 10.1073/pnas.0501345102. 16051704.
14. Kim T.K. Maniatis T. 1996. Regulation of interferon-activated STAT1 by the ubiquitin-proteasome pathway. Science, 273: 1717-1719. 10.1126/science.273.5282.1717. 8781235.
15. Manara M.C. Serra M. Benini S. Picci P. Scotlandi K. 2004. Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells. Int. J. Oncol. 24 (2): 365-372. 10.3892/ijo.24.2.365. 14719113.
16. Meier J.A. Larner A.C. 2014. Toward a new STATe: the role of STATs in mitochondrial function. Semin. Immunol. 26 (1): 20-28. 10.1016/j.smim.2013.12.005. 24434063.
17. Myers M.P. Andersen J.N. Cheng A. Tremblay M.L. Horvath C.M. Parisien J.P. et al 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276: 47771-47774. 10.1074/jbc.C100583200. 11694501.
18. Nakahira K. Kim H.P. Geng X.H. Nakao A. Wang X. Murase N. et al 2006. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med. 203: 2377-2389. 10.1084/jem.20060845. 17000866.
19. Park O. Jeong W.I. Wang L. Wang H. Lian Z.X. Gershwin M.E. Gao B. 2009 a. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology, 49: 1683-1694. 10.1002/hep.22813. 19205035.
20. Park S.J. Kim H.Y. Kim H. Park S.M. Joe E.H. Jou I. Choi Y.H. 2009 b. Oxidative stress induces lipid-raft-mediated activation of Src homology 2 domain-containing protein-tyrosine phosphatase 2 in astrocytes. Free Radic. Biol. Med. 46: 1694-1702. 10.1016/j.freeradbiomed.2009.03.026. 19348936.
21. Parton R.G. del Pozo M.A. 2013. Caveolae as plasma membrane sensors, protectors and organizers. Nat. Rev. Mol. Cell Biol. 14: 98-112. 10.1038/nrm3512. 23340574.
22. Sehgal P.B. 2003. Plasma membrane rafts and chaperones in cytokine/STAT signaling. Acta Biochim. Pol. 50: 583-594. 14515141.
23. Shen Y. Devgan G. Darnell J.E. Bromberg J.F. 2001. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl. Acad. Sci. U.S.A. 98: 1543-1548. 10.1073/pnas.98.4.1543. 11171987.
24. Shi Y. Gochuico B.R. Yu G. Tang X. Osorio J.C. Fernandez I.E. et al 2013. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling. Am. J. Respir. Crit. Care Med. 188 (7): 831-841. 10.1164/rccm.201303-0434OC. 23924348.
25. Stanford S.M. Ahmed V. Barrios A.M. Bottini N. 2014. Cellular Biochemistry Methods for Investigating Protein Tyrosine Phosphatases. Antioxid. Redox Signal. 20 (14): 2160-2168. 10.1089/ars.2013.5731. 24294920.
26. Stephanou A. Latchman D.S. 2005. Opposing actions of STAT-1 and STAT-3. Growth Factors, 23: 177-182. 10.1080/08977190500178745. 16243709.
27. Tebbutt N.C. Giraud A.S. Inglese M. Jenkins B. Waring P. Clay F.F. et al 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8: 1089-1097. 10.1038/nm763. 12219085.
28. Thannickal V.J. Toews G.B. White E.S. Lynch J.P. Martinez F.J. 2004. Mechanisms of pulmonary fibrosis. Annu. Rev. Med. 55: 395-417. 10.1146/annurev.med.55.091902.103810. 14746528.
29. Wang B.X. Platanias L.C. Fish E.N. 2013. STAT activation in malignancies: roles in tumor progression and in the generation of antineoplastic effects of IFNs. J. Interferon Cytokine Res. 33: 181-188. 10.1089/jir.2012.0154. 23570384.
30. Wang X.M. Zhang Y. Kim H.P. Zhou Z. Feghali-Bostwick C.A. Liu F. et al 2006. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. 203: 2895-2906. 10.1084/jem.20061536. 17178917.
31. Wang X.M. Kim H.P. Nakahira K. Ryter S.W. Choi A.M. 2009. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol. 182: 3809-3818. 10.4049/jimmunol.0712437. 19265160.
32. Williams T.M. Sotgia F. Lee H. Hassan G. Di Vizio D. Bonuccelli G. et al 2006. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. Am. J. Pathol. 169: 1784-1801. 10.2353/ajpath.2006.060590. 17071600.
33. Zhao Y.Y. Liu Y. Stan R.V. Fan L. Gu Y. Dalton N. et al 2002. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc. Natl. Acad. Sci. U.S.A. 99: 11375-11380. 10.1073/pnas.172360799. 12177436.